Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Alim Ramji

Orthopaedic Trauma Trumbull, CT Medical Doctor

NPI 1548684681 CMS profile 10151468

888 White Plains Rd Ste 105&106, Trumbull, CT 06611

Open in the dashboard

General payments

$36,398

140 records reported · program years 2021–2025

Research payments

$1,750

Paid to them · 1 record reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alim Ramji of Trumbull, CT is reported in the CMS Open Payments database as having received $36,398 across 140 general payments and $1,750 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,731 58
2025 Research $1,750 1
2024 General $13,435 52
2023 General $1,415 18
2022 General $1,784 11
2021 General $34 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alim Ramji
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Alim Ramji were reported at $19,731. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Alim Ramji Orthopaedic Trauma median Middle half National median
2019 $0 $1,475 $264–$6,401 $163
2020 $0 $596 $120–$4,020 $114
2021 $34 $919 $171–$4,697 $132
2022 $1,784 $1,547 $272–$7,240 $149
2023 $1,415 $1,330 $247–$5,875 $160
2024 $13,435 $1,288 $277–$6,797 $164
2025 $19,731 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Bone Support Inc. $19,102 18 payments
  2. Stryker Corporation $5,909 67 payments
  3. Skeletal Dynamics Inc $3,290 8 payments
  4. Smith+Nephew, Inc. $2,572 11 payments
  5. Medartis Inc. $1,632 5 payments
  6. Synthes GmbH $1,038 1 payment
  7. SI-BONE, Inc. $851 6 payments
  8. CurvaFix, Inc. $738 6 payments
  9. DePuy Synthes Sales Inc. $389 7 payments
  10. Heron Therapeutics, Inc. $302 3 payments
  11. Other $575 8 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $18,075 10 payments
  2. Food and Beverage $8,584 114 payments
  3. Travel and Lodging $7,339 15 payments
  4. Education $2,400 1 payment
Products named General payments · program years 2021–2025
  1. CERAMENTBONE VOID FILLER $19,102 18 payments
  2. CERAMENT G $19,102 18 payments
  3. IMPlate $3,290 8 payments
  4. IJS $3,290 8 payments
  5. Geminus $3,290 8 payments
  6. Align $3,290 8 payments
  7. PICO $2,517 9 payments
  8. Versajet $1,847 7 payments
  9. GRAFIX $1,847 7 payments
  10. COLLAGENASE SANTYL $1,847 7 payments
  11. Other $12,011 125 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. Bone Suppport AB $1,750 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

132

Median for Orthopedic Surgery: 203

Drug cost

$963

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 31 $217
Methocarbamol Generic 12 $194
Ibuprofen Generic 21 $194
Tramadol Hcl Generic 29 $143
Meloxicam Generic 27 $108
Gabapentin Generic 12 $107

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$62,727

Medicare's payments for the services billed

Medicare patients

127

Average age 78

Services billed

528

83 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Osteoporosis 38%
Ischemic heart disease 28%
Diabetes 27%
Chronic kidney disease 27%
Depression 25%
Atrial fibrillation 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

141 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record